CurrentEmpire BluecrossPolicy 09-600

Therapeutic Parenteral Drug Administration

Guidance for review and benefit determination of therapeutic parenteral drug administration for dental services (e.g., antibiotics, steroids, anti-inflammatories) provided to plan members; applies to providers whose claims are reviewed under the dental plan.

Policy Summary

PayerEmpire Bluecross

PolicyTherapeutic Parenteral Drug Administration

Policy CodePolicy 09-600

Change TypeNo material changes

Effective DateJan 1, 2022

Next Review Date

Key ActionSubmit the medication name and dosage (and clinical chart notes if requested) for benefit consideration.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

2CDT codes listed

2022-01-01Publish date

10/30/2021Last review date

Antibiotics/SteroidsMedication examples

Coverage Criteria

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Clinical Indication: Administration is therapeutic (for example: antibiotics, steroids, anti-inflammatory or other therapeutic medications) intended to improve surgical healing, reduce pain and/or treat or prevent infection; not for sedative, anesthetic, or reversal agents.

based on chunk 1 and chunk 3

Route: Parenteral route: intravenous, intramuscular, subcutaneous, or intradermal.

based on chunk 3

Documentation: The name and dosage of the medication administered must be submitted for benefit consideration; clinical chart notes and narrative may be requested to explain the rationale for the medication.

based on chunk 3

Not Experimental/Investigational: Procedure or medication is not considered experimental, investigational or unproven.

based on chunk 3

Not Cosmetic: Drug administration is not performed primarily for cosmetic purposes.

based on chunk 3 and chunk 1

Therapeutic parenteral drug administration is reviewed for benefit determination against the plan’s contractual and generally accepted standards of dental care. Administration of sedative, anesthetic or reversal agents is excluded from coverage. Additionally, drug administration performed primarily for cosmetic purposes is not a benefitted service and may be denied. Providers should submit required documentation (see Provider Actions) so the plan can determine whether the service meets contractual medical necessity.

Procedures and medications that are considered experimental, investigational or unproven are not benefitted. Such requests may be denied; when benefit consideration is requested, the plan may require supporting clinical information to demonstrate that the drug and its route of administration are accepted and established for the intended dental indication.

Provider Actions & Requirements

Prior Authorization

Prior Authorization / Benefit Review — Submission Requirements

Prior authorization or benefit review may be required. Submit the medication name and dosage when requesting benefit consideration. Provide clinical chart notes or narrative if requested to explain the medical rationale for the parenteral medication.

Required: medication name and dosage
Clinical chart notes/narrative may be requested

Step Therapy

No step therapy requirements are specified for therapeutic parenteral drug administration under this policy.

Documentation Required

Required Documentation

The name and dosage of the administered medication must be submitted for benefit consideration. Clinical chart notes and narrative may be requested to support medical necessity and the rationale for the drug administration.

Medication name and dosage required
Clinical chart notes/narrative may be requested

Denial Risk

Experimental/Unproven Procedures

Procedures or drug uses that are experimental, investigational or unproven are not benefitted and may be denied. Do not bill or expect coverage for parenteral drug administrations determined to be experimental or unproven.

Experimental/investigational/unproven procedures are not covered

Denial Risk

Cosmetic Use

Drug administration for cosmetic purposes is not a benefitted service and may be denied.

Cosmetic use is not covered

Background

Therapeutic parenteral drug administration in the dental setting refers to single or multiple administrations of medications such as antibiotics, steroids, and other anti-inflammatory drugs intended to improve surgical healing, reduce pain and/or prevent or treat infection. The parenteral route includes any technique in which the route of administration is intravenous, intramuscular, subcutaneous, or intradermal. Benefit review is performed to ensure the medication, dose, and indication meet contractual and generally accepted standards of dental practice.

Definitions

Parenteral administration — routes

DefinitionParenteral administration: any technique in which the route of administration is intravenous, intramuscular, subcutaneous or intradermal.

Included routesIntravenous (IV): delivery directly into a vein.

Included routesIntramuscular (IM): injection into the muscle tissue.

Included routesSubcutaneous (SC): injection beneath the skin into subcutaneous tissue.

Included routesIntradermal (ID): injection into the dermal layer of the skin.

Therapeutic parenteral drug administration (dental)

DefinitionTherapeutic parenteral drug administration (dental): single or multiple administrations of antibiotics, steroids, anti-inflammatory drugs or other therapeutic medications intended to improve surgical healing, reduce pain and/or prevent or treat infection.

Examples of medicationsAntibiotics, steroids, anti-inflammatory drugs.

ExclusionsNot to be used for administration of sedative, anesthetic or reversal agents; drug administration performed primarily for cosmetic purposes is not a benefitted service.

Documentation requirementName and dosage of the medication administered must be submitted for benefit consideration; clinical chart notes and narrative may be requested to explain rationale.

Policy Summary

PayerEmpire Bluecross

PolicyTherapeutic Parenteral Drug Administration

Policy CodePolicy 09-600

Change TypeNo material changes

Effective DateJan 1, 2022

Next Review Date

Key ActionSubmit the medication name and dosage (and clinical chart notes if requested) for benefit consideration.

SourceLink

On This Page

D9610	Therapeutic parenteral drug, single administration
D9612	Therapeutic parenteral drugs, two or more administrations, different medications

OpenPayer

Therapeutic Parenteral Drug Administration

Coverage Criteria

Coding

Provider Actions & Requirements

Background

Definitions